STAT Plus: White House insists drug prices are falling, but critics say its report is flawed
In a bid to seize the narrative on prescription drug pricing, the White House issued a report that criticized a steady stream of news stories for saying prices are rising and, instead, argued that an economic index shows prices have actually fallen recently.
However, the effort was quickly denounced because the index does not account for all medicines, including some newer and pricier drugs.
